CANCER, GENOMICS AND CONSULTING LTD
Executive Summary
Cancer, Genomics and Consulting Ltd is a promising micro-sized enterprise leveraging a unique combination of medical, biotechnological, and IT consulting expertise to address emerging needs in precision oncology. Its strong financial footing and strategic location underpin growth potential through service expansion and partnerships, though scaling operational capacity and managing regulatory complexities remain critical challenges to ensure sustainable competitive advantage.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 15/07/2515 July 2025 New | Confirmation statement made on 2025-07-15 with no updates |
| 22/07/2422 July 2024 | Micro company accounts made up to 2024-06-30 |
| 15/07/2415 July 2024 | Confirmation statement made on 2024-07-15 with no updates |
| 30/06/2430 June 2024 | Annual accounts for year ending 30 Jun 2024 |
| 08/01/248 January 2024 | Change of details for Dr Alexander Aresh Azizi as a person with significant control on 2024-01-08 |
| 08/01/248 January 2024 | Director's details changed for Dr Alexander Aresh Azizi on 2024-01-08 |
| 16/08/2316 August 2023 | Micro company accounts made up to 2023-06-30 |
| 15/07/2315 July 2023 | Confirmation statement made on 2023-07-15 with no updates |
| 30/06/2330 June 2023 | Annual accounts for year ending 30 Jun 2023 |
| 30/06/2230 June 2022 | Annual accounts for year ending 30 Jun 2022 |
| 16/07/2116 July 2021 | Incorporation |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company